Pharma & Bio
Lifestyle
Out of 253 Stocks, Only 21 Rose—Market in Shambles... DuChemBio Co, LTD, Yuhan, and Curiox Were the Exceptions [Bio Market Roundup]
On the 15th, the domestic pharmaceutical and biotech sector could not escape “Black Thursday.” Most stocks were unable to avoid declines. In the pharmaceutical sector, only 12 out of 161 stocks posted…
- 2026-10-17 07:21:02
- KIM JI-WAN
Technology
Koo Bo-sung, CEO of MBD, “Automated Cell Culture System Integrated with a Robotic Arm to Be Commercialized Next Year”
Koo Bo-sung, CEO of MBDI. (Photo courtesy of MBDI)
“Our goal is to automate the entire process—from cell isolation and culture to drug treatment, image analysis, and result reporting—simply by ins…
- 2026-10-16 11:01:02
- Minji Son
Technology
Kim Ho-woong, Head of JAL Headquarters: “We’ll Secure and Maintain Our Lead in Japan with Omriclo… Our 11 Years of Infrastructure Is Our Strength” [WAC 2026]
Kim Ho-woong, Head of Celltrion’s JAL Division, explained the company’s strategy for expanding into the Japanese market, centered on Omriclo, during an interview with Edaily in Kyoto, Japan, on the af…
- 2026-10-16 08:02:02
- KIM SAE-MI
Lifestyle
While Moderna Uses 34, NeoGenLogic Uses 61… NeoGenLogic Plays Its Ace Card with a Customized Liver Cancer Vaccine Based on a Differentiated ‘Design’
Neogen Logic is embarking on the development of a personalized cancer vaccine to suppress recurrence after liver cancer surgery.
Choi Jeong-kyun, CEO of Neogen Logic and a professor at the Korea A…
- 2026-10-16 07:41:02
- KIM JI-WAN
Technology
[Exclusive] Peptron, Inc., which touted “once a month” and “up to 3 months”… Efficacy tests in its patent were conducted at intervals of up to two weeks
Peptron, Inc.(087010)Although the patent for a long-acting glucagon-like peptide-1 (GLP-1) formulation recently granted to includes a 1- to 3-month dosing cycle, analysts note that the company has not…
- 2026-10-16 07:02:03
- KIM SAE-MI
Lifestyle
Inventage Lab and Qurient Rebound, Hanmi Falls 10% as Eppe Prices Emerge [K-Bio Pulse]
Pharmaceutical and biotech stocks reacted to company-specific developments on October 14, following broad sector weakness the previous day. Inventage Lab drew attention with a gain of more than 14%, d…
- 2026-10-16 06:31:02
- SONG YOUNG-DOO
Lifestyle
Inventage Lab Inc. and Qurient Co., Ltd. See Sharp Rebounds… HanmiPharm Plummets 10% After ‘Efe Price Revealed’ [Bio Roundup]
Pharmaceutical and biotech stocks, which had been weak across the board the previous day, saw share price fluctuations driven by individual developments on the 14th. Among them, Inventage Lab Inc. dre…
- 2026-10-16 06:31:01
- SONG YOUNG-DOO
Lifestyle
Dicigen to Launch OncoFree in Taiwan... Proving Market Value Through Export Diversification
Digen, a genomics-based precision medicine company, is accelerating its global expansion with “OncoFREE,” a breast cancer prognosis prediction test that utilizes next-generation sequencing (NGS) techn…
- 2026-10-15 09:59:01
- YU JIN-HEE
Technology
'Launch Imminent': Could the Price of 'Epe' Be Under 100,000 Won?
All eyes are on whether “Epe,” the first domestically developed glucagon-like peptide (GLP)-1 class obesity drug from Hanmi Pharmaceutical ( HanmiPharm(128940)), will serve as a catalyst for the comme…
- 2026-10-15 07:36:03
- NA EUN-KYUNG
Lifestyle
Olix Pharmaceuticals, Inc. Plummets 14% After Clinical Trial Application Rejected; ROKIT HEALTHCARE Inc. Hits 52-Week Low [Bio Spotlight]
Olix Pharmaceuticals, Inc. plummeted more than 14% as the rejection of its application for a clinical trial in New Zealand for a potential treatment for age-related macular degeneration coincided with…
- 2026-10-15 07:02:03
- SONG YOUNG-DOO
PHARM EDAILY
Shorts